Intest Res > v.17(3)

18 results

283 Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
Hyuk Yoon
KMSID: 1516081444   Intest Res. 2019;17(3):283-284.   Published online 2019 July 25    DOI: http://dx.doi.org/10.5217/ir.2019.00070
      
285 Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong
KMSID: 1516081441   Intest Res. 2019;17(3):285-310.   Published online 2019 May 31    DOI: http://dx.doi.org/10.5217/ir.2019.00026
      
311 Stem cell-based therapy for inflammatory bowel disease
Hiromichi Shimizu, Kohei Suzuki, Mamoru Watanabe, Ryuichi Okamoto
KMSID: 1516081443   Intest Res. 2019;17(3):311-316.   Published online 2019 July 25    DOI: http://dx.doi.org/10.5217/ir.2019.00043
      
317 Prevalence and risk factors of colorectal cancer in Asia
Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang
KMSID: 1516081440   Intest Res. 2019;17(3):317-329.   Published online 2019 May 20    DOI: http://dx.doi.org/10.5217/ir.2019.00021
      
330 Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Homayoon Vahedi, Reza Malekzadeh
KMSID: 1516081433   Intest Res. 2019;17(3):330-339.   Published online 2019 April 24    DOI: http://dx.doi.org/10.5217/ir.2018.00157
      
340 Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
Sadik Saman, Martin Goetz, Judith Wendler, Nisar P. Malek, Jan Wehkamp, Thomas Klag
KMSID: 1516081439   Intest Res. 2019;17(3):340-348.   Published online 2019 May 31    DOI: http://dx.doi.org/10.5217/ir.2019.00012
      
349 Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
KMSID: 1516081428   Intest Res. 2019;17(3):349-356.   Published online 2019 February 8    DOI: http://dx.doi.org/10.5217/ir.2018.00064
      
357 Risk of surgery in patients with stricturing type of Crohn’s disease at the initial diagnosis: a single center experience
Yuji Maehata, Yutaka Nagata, Tomohiko Moriyama, Yuichi Matsuno, Atsushi Hirano, Junji Umeno, Takehiro Torisu, Tatsuya Manabe, Takanari Kitazono, Motohiro Esaki
KMSID: 1516081431   Intest Res. 2019;17(3):357-364.   Published online 2019 February 21    DOI: http://dx.doi.org/10.5217/ir.2018.00107
      
365 Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis
Alissa Walsh, Lawrence Matini, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, John Geddes, Guy Goodwin, Gary Collins, Simon Travis, Michele Peters
KMSID: 1516081438   Intest Res. 2019;17(3):365-374.   Published online 2019 May 31    DOI: http://dx.doi.org/10.5217/ir.2018.00173
      
375 Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
KMSID: 1516081427   Intest Res. 2019;17(3):375-386.   Published online 2019 February 12    DOI: http://dx.doi.org/10.5217/ir.2018.00141
      
387 Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease
Prasenjit Das, Gaurav PS Gahlot, Alka Singh, Vandana Baloda, Ramakant Rawat, Anil K Verma, Gaurav Khanna, Maitrayee Roy, Archana George, Ashok Singh, Aasma Nalwa, Prashant Ramteke, Rajni Yadav, Vineet Ahuja, Vishnubhatla Sreenivas, Siddhartha Datta Gupta, Govind K Makharia
KMSID: 1516081435   Intest Res. 2019;17(3):387-397.   Published online 2019 April 22    DOI: http://dx.doi.org/10.5217/ir.2018.00167
      
398 Endoscopic features of gastrointestinal stromal tumor in the small intestine
Yutaro Ihara, Takehiro Torisu, Tomohiko Moriyama, Junji Umeno, Atsushi Hirano, Yasuharu Okamoto, Yoshifumi Hori, Hidetaka Yamamoto, Takanari Kitazono, Motohiro Esaki
KMSID: 1516081437   Intest Res. 2019;17(3):398-403.   Published online 2019 July 25    DOI: http://dx.doi.org/10.5217/ir.2018.00161
      
404 Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer
In Sub Jung, Cheol Min Shin, Sung Jae Park, Young Soo Park, Hyuk Yoon, Hyun Jin Jo, Nayoung Kim, Dong Ho Lee
KMSID: 1516081429   Intest Res. 2019;17(3):404-412.   Published online 2018 November 12    DOI: http://dx.doi.org/10.5217/ir.2018.00072
      
413 Clinical comparison of low-volume agents (oral sulfate solution and sodium picosulfate with magnesium citrate) for bowel preparation: the EASE study
Jeeyeon Kim, Hyun Gun Kim, Kyeong Ok Kim, Hyung Wook Kim, Jongha Park, Jeong-Sik Byeon, Sung-Wook Hwang, Hyun Deok Shin, Jeong Eun Shin, Hyo-Joon Yang, Hyun Seok Lee, Yunho Jung, Young-Seok Cho, Young Eun Joo, Dae-Seong Myung, Kyu Chan Huh, Eu Mi Ahn
KMSID: 1516081436   Intest Res. 2019;17(3):413-418.   Published online 2019 April 8    DOI: http://dx.doi.org/10.5217/ir.2018.00156
      
419 Is stool frequency associated with the richness and community composition of gut microbiota?
Hye Jung Kwon, Jong Hyun Lim, Dongmin Kang, Sanghyun Lim, Seun Ja Park, Jae Hyun Kim
KMSID: 1516081430   Intest Res. 2019;17(3):419-426.   Published online 2019 February 7    DOI: http://dx.doi.org/10.5217/ir.2018.00149
      
427 Evaluation of symptoms and symptom combinations in histamine intolerance
Wolfgang J. Schnedl, Sonja Lackner, Dietmar Enko, Michael Schenk, Sandra J. Holasek, Harald Mangge
KMSID: 1516081432   Intest Res. 2019;17(3):427-433.   Published online 2019 March 7    DOI: http://dx.doi.org/10.5217/ir.2018.00152
      
434 Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings
Janice M. Cho, Laura Pestana, Ryan Pardi, Darrell S. Pardi, Sahil Khanna
KMSID: 1516081442   Intest Res. 2019;17(3):434-437.   Published online 2019 May 31    DOI: http://dx.doi.org/10.5217/ir.2019.00056
      
438 A pulmonary nodule in a patient with Crohn’s disease
Akira Hokama, Shusaku Haranaga, Takanobu Sasaki, Hirofumi Matsumoto, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Saifun Nahar, Jiro Fujita
KMSID: 1516081434   Intest Res. 2019;17(3):438-439.   Published online 2019 February 11    DOI: http://dx.doi.org/10.5217/ir.2019.00010
      
Articles from Intestinal Research are provided here courtesy of Korean Association for the Study of Intestinal Diseases